NCT03786081 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03786081
Title	Safety and Efficacy of Tisotumab Vedotin in Combination With Other Cancer Agents in Subjects With Cervical Cancer
Recruitment	Terminated
Gender	female
Phase	Phase Ib/II
Variant Requirements	No
Sponsors	Genmab
Indications	cervical adenosquamous carcinoma cervical adenocarcinoma cervical squamous cell carcinoma
Therapies	Bevacizumab + Tisotumab vedotin-tftv Carboplatin + Tisotumab vedotin-tftv Pembrolizumab + Tisotumab vedotin-tftv
Age Groups:	adult \| senior
Covered Countries	USA \| TUR \| NLD \| ITA \| IRL \| GBR \| ESP \| DNK \| CZE \| BEL

NCT03786081
Clinical Trial Detail